Skip to Main Content

Evaluation of the TULSA-PRO MRI-Guided Transurethral Ultrasound Prostate Ablation Device in Patients With Localized Prostate Cancer: a Prospective, Single-Arm, Pivotal Clinical Study

Conditions

Prostate

What is the purpose of this trial?

A prospective, multi-center, single-arm study, planned in 150 patients. The primary objective of the study is to further evaluate the safety and efficacy of a magnetic resonance imaging (MRI)-guided transurethral ultrasound therapy system (TULSA-PRO) intended to ablate prostate tissue of patients with localized, organ-confined prostate cancer.

  • Ages
    45 years - 80 years
  • Gender
    Male only
Find out more about who can participate in this trial
  • Trial with
    Radiological Society of North America
  • Start Date
    05/05/2021
  • End Date
    06/30/2023

For more information about this study, contact:

Kristin DeFrancesco

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

Volunteer Now

Principal Investigator

Sub-Investigators

  • Last Updated
    05/12/2022
  • Study HIC
    #2000029224

Contact Information

For more information about this study, including how to volunteer, contact Kristin DeFrancesco

Volunteer Now